Stay updated on Switching to Cabotegravir and Rilpivirine: Clinical Trial

Sign up to get notified when there's something new on the Switching to Cabotegravir and Rilpivirine: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Switching to Cabotegravir and Rilpivirine: Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.2 to version 2.16.3.
    Difference
    0.0%
    Check dated 2025-06-13T15:58:04.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.0%
    Check dated 2025-06-06T09:34:43.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.
    Difference
    0.3%
    Check dated 2025-05-30T04:31:46.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.0, replacing the previous version 2.15.2.
    Difference
    0.0%
    Check dated 2025-05-23T01:30:21.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.0%
    Check dated 2025-05-01T05:51:20.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    The page has been updated to include new information about the Rilpivirine Injectable Suspension (RPV LA) and its use in HIV treatment, while significant details about the ATLAS study have been removed.
    Difference
    18%
    Check dated 2025-04-16T14:41:58.000Z thumbnail image

Stay in the know with updates to Switching to Cabotegravir and Rilpivirine: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Switching to Cabotegravir and Rilpivirine: Clinical Trial page.